286 related articles for article (PubMed ID: 32860338)
1. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
[TBL] [Abstract][Full Text] [Related]
2. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
[TBL] [Abstract][Full Text] [Related]
6. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
[TBL] [Abstract][Full Text] [Related]
7. Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease.
Ravanidis S; Bougea A; Papagiannakis N; Maniati M; Koros C; Simitsi AM; Bozi M; Pachi I; Stamelou M; Paraskevas GP; Kapaki E; Moraitou M; Michelakakis H; Stefanis L; Doxakis E
Mov Disord; 2020 Mar; 35(3):457-467. PubMed ID: 31799764
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
9. Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients.
Jiang Y; Chen J; Sun Y; Li F; Wei L; Sun W; Deng J; Yuan Y; Wang Z
Front Neurol; 2021; 12():738530. PubMed ID: 34899562
[No Abstract] [Full Text] [Related]
10. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
11. Cell-free microRNAs in Parkinson's disease: potential biomarkers that provide new insights into disease pathogenesis.
Doxakis E
Ageing Res Rev; 2020 Mar; 58():101023. PubMed ID: 32001380
[TBL] [Abstract][Full Text] [Related]
12. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
14. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
15. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
17. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
Guévremont D; Roy J; Cutfield NJ; Williams JM
Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis.
Zhang X; Wang X; Wu J; Peng J; Deng X; Shen Y; Yang C; Yuan J; Zou Y
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961674
[TBL] [Abstract][Full Text] [Related]
20. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
